Kyverna shares safety data for CAR-T; Evotec gets $75M milestone

Plus, news about Boundless Bio, Pelage, Actuate Therapeutics and Mersana Therapeutics:

Kyverna Therapeutics touts early safety of CAR-T therapy: The biotech said the first 36 …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Pfizer, Samsung Biologics build on biosimilar deals now worth $897M

Pfizer has expanded upon a pair of agreements with Samsung Biologics to make its biosimilars in a deal worth almost $900 million. According to a

July 6, 2023

Achieve Life Sciences nabs $124M; Pierre Fabre buys pan-RAF program from Kinnate

Plus, news about Tarsus Pharmaceuticals, Humacyte, Stemcell Technologies and SQZ Biotechnologies: Achieve Life Sciences raises $124M, details plans for NDA: The company plans to submit

March 2, 2024

A Moral Code: Ethical Dilemmas in Medicine

Listen and subscribe to Anamnesis by searching for MedPod Today on Apple and Spotify so you don’t miss the next episode. Amy Ho: Hey everyone

October 26, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.